Astrazeneca Pharma India: Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025.

Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended December 31 2025.